The criteria for tirzepatide (Zepbound) primarily involve specific Body Mass Index (BMI) thresholds and the presence of weight-related health conditions for adults seeking chronic weight management.
Understanding the Criteria for Tirzepatide (Zepbound)
Tirzepatide, marketed as Zepbound for weight management, has received approval for use in adults based on specific health and BMI criteria. It is intended for chronic weight management, meaning it's used over a longer period as part of a comprehensive weight loss plan.
Key Eligibility Requirements
To be considered for tirzepatide, adult individuals must meet one of the following criteria related to their Body Mass Index (BMI) and health status:
- Adults with Obesity: A Body Mass Index (BMI) of 30 kilograms per square meter (kg/m²) or greater.
- Adults who are Overweight: A Body Mass Index (BMI) of 27 kg/m² or greater, accompanied by at least one weight-related condition.
This distinction is crucial, as overweight individuals need an additional health factor for eligibility, whereas those classified as obese meet the primary criteria based on BMI alone.
What is a Weight-Related Condition?
For adults who are overweight (BMI of 27 kg/m² or greater), the requirement of "at least one weight-related condition" is vital. While specific examples are not provided in detail in the current reference, common weight-related conditions often include, but are not limited to:
- High blood pressure (hypertension)
- Type 2 diabetes
- High cholesterol (dyslipidemia)
- Obstructive sleep apnea
- Heart disease
These conditions highlight the medical necessity for weight management beyond just cosmetic concerns.
Summary of Criteria
The table below summarizes the core criteria for tirzepatide eligibility:
| Category | Body Mass Index (BMI) | Additional Requirements |
|---|---|---|
| Adults with Obesity | ≥ 30 kg/m² | None specified for eligibility beyond BMI. |
| Adults who are Overweight | ≥ 27 kg/m² | Must have at least one weight-related condition. |
It's important to remember that tirzepatide is an injectable medication intended for chronic use alongside a reduced-calorie diet and increased physical activity.
Where to Find More Information
For official and comprehensive information regarding the approval and use of tirzepatide (Zepbound), you can refer to reputable health authorities. The U.S. Food and Drug Administration (FDA) provides detailed press announcements on medication approvals.
- Learn more about the FDA's approval of Zepbound for chronic weight management directly from their press announcements.
